Launch excellence: why successful product launches begin years before regulatory approval

In the life sciences, a successful product launch is still too often regarded as the final phase of product development. In reality, the commercial success of an innovative therapy is determined years earlier. Decisions made during clinical development, evidence generation, product positioning and market access preparation directly influence the speed of adoption, reimbursement by healthcare systems and ultimate commercial performance.

For organisations investing in innovation, launch excellence is therefore not a project centred on the regulatory approval date. It is an integrated strategic discipline that connects the entire product lifecycle. In a market where development costs are rising, competition is intensifying and healthcare systems are becoming more critical, launch excellence increasingly determines the difference between market leadership and a missed commercial opportunity.

The first day of a launch begins years earlier

The most successful organisations do not treat a product launch as an operational initiative, but as a strategic programme that begins during the early stages of development. From the moment a promising therapy demonstrates clinical potential, commercial, medical, regulatory and market access experts become involved in establishing the conditions for a successful introduction.

This early collaboration helps determine which clinical endpoints are assessed, what economic evidence is required, how the value proposition is developed and which needs must be addressed among healthcare professionals, patients and payers.

When this alignment takes place only shortly before regulatory approval, it is often too late to influence fundamental decisions.

Cross-functional collaboration determines success

Launch excellence is inherently multidisciplinary. A successful introduction is possible only when clinical development, regulatory affairs, medical affairs, market access, commercial, supply chain and manufacturing operate according to a shared strategy from the outset.

In practice, this alignment is often one of the greatest challenges. Functions frequently operate according to different objectives, timelines and priorities, resulting in missed opportunities. Organisations that have embedded launch excellence structurally therefore invest deliberately in integrated governance, shared decision-making and clear accountability throughout launch preparation.

The quality of collaboration ultimately determines the quality of the launch.

Preparing the market before the product becomes available

Innovative therapies increasingly require fundamental changes in how care is organised. New treatment approaches may require changes to diagnostics, patient selection, treatment guidelines or funding models. This creates an additional dimension within launch excellence: market shaping.

Leading organisations therefore invest well before regulatory approval in scientific education, stakeholder engagement, evidence generation and awareness of unmet medical needs. The objective is not to create demand, but to ensure that healthcare systems, healthcare professionals and other stakeholders are prepared for the introduction of new treatment options.

This preparatory phase plays a decisive role in determining how rapidly innovation ultimately reaches patients.

Launch readiness extends beyond operational preparation

Launch readiness traditionally focused on operational aspects such as inventory management, supply chain, sales training and marketing materials. While these elements remain indispensable, they represent only part of the overall requirements.

A modern launch readiness strategy includes:

A compelling scientific value proposition;
An integrated market access strategy;
Medical and commercial alignment;
Robust supply chain and manufacturing planning;
Digital and omnichannel engagement;
Scenario analysis and risk management;
Global coordination with flexibility for local market differences.

Organisations that address these elements in an integrated manner are better equipped to manage uncertainty and respond more rapidly to changing market conditions.

Global strategy, local execution

For international life sciences organisations, a key challenge lies in balancing a consistent global launch strategy with the differing requirements of local markets.

Reimbursement systems, regulations, treatment guidelines and healthcare structures vary considerably between countries. This requires a global vision with sufficient flexibility to enable effective local execution. Organisations that excel in this area combine central coordination with an in-depth understanding of regional market dynamics and local stakeholder expectations.

Launch excellence is therefore as much a matter of international coordination as it is a commercial challenge.

The future of launch excellence

The introduction of innovative therapies will become increasingly complex in the coming years. Personalised medicine, cell and gene therapies, digital health solutions and AI-enabled healthcare are changing not only the nature of products, but also the expectations of healthcare professionals, patients and healthcare systems.

Launch excellence is consequently evolving further from project management towards strategic leadership. Organisations must collaborate earlier, anticipate developments more rapidly and make better-integrated decisions throughout the entire product lifecycle.

Successful product launches are therefore rarely the result of flawless execution during the final months before regulatory approval. They are the culmination of years of strategic preparation in which science, market insight, medical expertise and commercial vision are connected from the outset.

In a sector where innovation is advancing ever more rapidly and the margin for error continues to narrow, this integrated approach will determine which organisations succeed not only in developing new therapies, but also in bringing them to market sustainably and successfully.

Working with Maxwell Benson? Discover the possibilities

Werken met Oliver Benson?